Lilly and Novo Nordisk are hoping to win over employers on the idea that obesity and its complications are already a huge cost in terms of healthcare, workers' compensation and disability. By offering ...

Wondr Plus delivers improved metabolic health outcomes and meaningful ROI for employers ready to tackle workforce obesity ...

Novo Nordisk has launched its blockbuster Wegovy weight-loss drug in China, adding the world’s second-largest economy to its ...

About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...

There’s no hard-and-fast rule for how long it’s safe to stay on Ozempic for weight loss. Novo Nordisk-sponsored studies lasting up to two years show that semaglutide is safe.

GLP-1-based drugs have a well-documented record of causing nausea, vomiting, diarrhea and other unpleasant gastrointestinal side effects. That is why pharma companies are keen to offer an alternative ...

Healthcare executives and investors expect an uptick in initial public offerings and corporate dealmaking in 2025, with ...

Peloton’s Robin Arzon discusses her type 1 diabetes diagnosis, what she wants you to know about the disease, and the ...

In a study by the Northwestern Medicine Canning Thoracic Institute in Chicago, the RNA in the SARS-CoV-2 virus was found to "trigger the development of a unique type of immune cell with anti-cancer ...

Diet Coke’s intense sweetness, caloric emptiness, and caffeine content hacks our most innate neurological and psychological ...

"Since more than half of U.S. adults who have taken GLP-1 receptor agonists state the therapy was difficult to afford, ...

Gundry MD® is proud to announce that one of its best-selling products, MCT Wellness™, has received over 3,400 positive ...